医学
内科学
宫颈癌
化疗
肿瘤科
癌症
总体生存率
癌症化疗
梅德林
放射治疗
肿瘤分期
作者
Krishnansu S. Tewari,Bradley J. Monk,Ignace Vergote,Austin Miller,Andreia C. de Melo,Hee-Seung Kim,Yong Man Kim,Alla Lisyanskaya,Vanessa Samouëlian,Domenica Lorusso,Fernanda Damian,Chih-Long Chang,Evgeniy A. Gotovkin,Shunji Takahashi,Daniella Ramone,Joanna Pikiel,Beata Maćkowiak-Matejczyk,Eva M. Guerra Alía,Nicoletta Colombo,Yulia Makarova
标识
DOI：10.1056/nejmoa2112187
摘要
Survival was significantly longer with cemiplimab than with single-agent chemotherapy among patients with recurrent cervical cancer after first-line platinum-containing chemotherapy. (Funded by Regeneron Pharmaceuticals and Sanofi; EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 ClinicalTrials.gov number, NCT03257267.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
大力的灵雁
zzzz
贪玩的秋柔
AllRightReserved
HH
lizishu
畔畔
乐空思
wanci
科研狗
GingerF
浮浮世世
dew
Mic
湖工大保卫处
pcr163
昏睡的蟠桃
Rich
学术文献互助
皖公网安备34019202002308
